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Ozone is a common summertime pollutant
formed by reactions of ambient nitrogen
oxides and volatile organic compounds
(VOCs) in the presence of sunlight and heat.
Animal and human studies have identiﬁed spe-
ciﬁc effects O3 has on the respiratory system,
including alterations in airway epithelium
(Bromberg et al. 1991; Devalia et al. 1996;
Sandstrom et al. 1991; Wagner et al. 2001),
airway hyperresponsiveness (Devalia et al.
1996), airway infiltration by inflammatory
cells (Chitano et al. 1995), and enhancement
of antigen-associated airway inflammation
(Depuydt et al. 2002). Because O3 is a rela-
tively insoluble gas, it tends to pass through
the upper respiratory tract and penetrate deep
into the lung (Mathieu-Nolf 2002).
O3 has consistently been linked to acute
respiratory effects and to hospital admissions
in human populations living in highly pol-
luted areas (Ostro et al. 1995, 2001; Romieu
et al. 1996, 1997; Thurston et al. 1992). U.S.
Environmental Protection Agency (EPA)
standards based on peak 1-hr O3 concentra-
tions and maximum 8-hr running averages
have been established (U.S. EPA 2006), but
recent studies indicate that these standards
may not protect sensitive individuals (e.g.,
children with asthma) from acute respiratory
responses (Gent et al. 2003; Mortimer et al.
2000; Thurston et al. 1997).
Young children may be particularly sensi-
tive to O3, because signiﬁcant lung develop-
ment continues postnatally (Finkelstein and
Johnston 2004). Differences in lung anatomy
and physiology, ventilation rates, and organ
maturity between children and adults may
explain children’s greater vulnerability to air
pollutants (Mathieu-Nolf 2002). Infants, for
whom transient wheeze is common (reported
in up to 50% of healthy infants), and infants
with a genetic predisposition (e.g., maternal
asthma) may be even more sensitive to pollu-
tant effects. There has been a dearth of
research examining respiratory health effects
of O3 in infants who may be at greatest risk of
O3’s effects. In this study we examined acute
respiratory effects of relatively low O3 levels in
infants living in nonsmoking households.
Methods
Study population. A total of 12,128 women
delivering babies at one of five participating
hospitals in southwestern Virginia between
1994 and 1996 were screened for eligibility
into a cohort study investigating the effects of
exposure to acid aerosols on infant respiratory
health. Exclusion criteria included any smoking
in the household, infant death or adoption,
maternal age < 19 years, and non-English-
speaking respondent. The study was designed
to oversample households with exposure to
kerosene heaters (22%), the primary indoor
source of acid aerosols, and gas stoves (28%).
About half of the study families did not use
either a gas stove or a kerosene heater at all dur-
ing the year (e.g., they used an electric stove). A
total of 1,331 women were invited to partici-
pate, of whom 780 enrolled. During the sum-
mers of 1995 and 1996, study equipment was
set up at a central site in Virginia to monitor
daily levels of air pollutants. The current analy-
sis is limited to the 691 infants who were fol-
lowed between 10 June and 31 August 1995,
and/or 10 June and 31 August 1996. None of
the homes used kerosene heaters during this
study period.
The study was reviewed and approved by
the Yale Human Investigations Committee as
well as the institutional review boards of each
of the participating hospitals. A standardized
questionnaire was administered to mothers of
study infants at enrollment (when the infant
was 3–5 months of age) by a trained research
assistant. Informed consent was obtained
from the mother. The initial questionnaire
gathered detailed information on the health
history of the infant, household demographic
data, maternal health history, and dwelling
characteristics.
Outcome assessment: infant respiratory
symptoms. At the initial visit, mothers were
given a calendar on which to record infants’
daily respiratory symptoms, including
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OBJECTIVE: Recent studies indicate that the U.S. Environmental Protection Agency (EPA) ozone
standards may not protect sensitive individuals. In this study we examined respiratory effects of
ozone in infants who may be vulnerable, particularly if they are children of asthmatic mothers.
DESIGN: Women delivering babies at one of ﬁve hospitals in southwestern Virginia between 1994
and 1996 were invited to participate in a cohort study; 780 women enrolled. Ambient air quality
data (ozone and particulate matter) were collected at a central monitoring site.
PARTICIPANTS: This analysis is of 691 infants followed for approximately 83 days between 10 June
and 31 August 1995 and/or 1996; they contributed a total of 52,421 infant-days of follow-up.
Mothers were interviewed at enrollment and approximately biweekly to report infants’ daily symp-
toms. Repeated measures logistic regression models were run separately for wheeze, difficulty
breathing, and cough. Ozone metrics included 24-hr average, peak 1-hr, and maximum 8-hr aver-
age. Analyses were repeated for the 61 infants whose mothers had asthma.
RESULTS: For every interquartile-range increase in same-day 24-hr average ozone, likelihood of
wheeze increased 37% [95% conﬁdence interval (CI), 2–84%]. Among infants of asthmatic moth-
ers, same-day 24-hr average ozone increased likelihood of wheeze 59% (95% CI, 1–154%) and of
difﬁculty breathing 83% (95% CI, 42–136%). Maximum 8-hr ozone and peak 1-hr ozone were
associated with difﬁculty breathing, but not wheeze, in infants of asthmatic mothers. Ozone was
not associated with cough.
CONCLUSIONS: At levels of ozone exposure near or below current U.S. EPA standards, infants are at
increased risk of respiratory symptoms, particularly infants whose mothers have physician-
diagnosed asthma.
KEY WORDS: air pollution, difﬁculty breathing, infant symptoms, maternal asthma, wheeze.  Environ
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29 December 2005]wheeze, difficulty breathing, and cough. At
approximately biweekly intervals [median =
16 days; interquartile range (IQR) = 13–19
days] for 1 year, a research assistant called the
mother, who reported the presence or absence
of each symptom on each day during the
reporting period.
Exposure assessment: ambient air pollu-
tion and meteorology. Ambient air quality
data were collected at a central monitoring
site in Vinton, Virginia (greater Roanoke
area). Hourly O3 was collected by the
Department of Environmental Quality
(DEQ) (Richmond, VA) at this site and was
summarized into a) 24-hr average, b) peak
1-hr concentration, and c) maximum 8-hr
running average. During the summers of
1995 and 1996, integrated 24-hr particulate
mass—including particulate matter < 2.5 µm
in diameter (PM2.5) and particulate matter
< 10 µm in diameter (PM10)—was measured
using study equipment set up adjacent to the
DEQ monitoring site. Harvard-Marple
impactors (Air Diagnostics, Harrison, ME)
collected PM2.5 and PM10 samples at 10 and
4 L/min, respectively. Coarse particle (2.5 <
aerodynamic diameter < 10 µm) concentra-
tions were calculated as the difference
between PM10 and PM2.5 concentrations.
Hourly meteorological data were collected
from Roanoke Airport, located 6 miles from
the central monitoring site. The monitoring
sites were located within 115 miles of all ﬁve
hospitals from which subjects were recruited.
Statistical analysis. Each infant was fol-
lowed for 1 year, including 83 days during
the summer (10 June–31 August) of 1995
and/or 1996. This analysis is limited to the
summer period. The 691 infants who were
followed in either of the summers contributed
a total of 52,421 (91%) infant-days of follow-
up out of a possible 57,353 days (691 infants
× 83 days). A total of 61 infants (9%) whose
mothers had a history of physician-diagnosed
asthma contributed 4,449 infant-days. To
exploit the repeated observations for each
infant, we performed logistic regression analy-
ses using the GENMOD procedure in SAS
(version 8; SAS Institute Inc., Cary, NC)
with the AR1 autoregressive correlation struc-
ture among repeated observations for the same
individual were performed. The GENMOD
procedure uses the generalized estimating
equations (GEE) method for fitting general-
ized linear models to handle correlated
repeated measures data. To determine the
appropriate form for the correlation structure
among the repeated measures for each indi-
vidual, we fitted an m-dependent (m = 14)
model that did not assume a particular rela-
tionship between correlation and lag. A graph
was constructed (not shown), which revealed
that log correlation was linearly related to the
lag, consistent with an AR1 model, which we
used for the analysis presented here. We ran
separate models for the following outcomes:
wheeze, difficulty breathing, and cough. We
examined three different O3 metrics sepa-
rately: 24-hr average, peak 1-hr, and maxi-
mum 8-hr running average. Single pollutant
and co-pollutant models for each outcome
were built. Pollutant measures for same day
and previous day were considered. Single-
pollutant models of O3 effects controlled for
daytime temperature and humidity, while co-
pollutant models controlled for PM2.5, coarse
particles, temperature, and humidity. The
repeated-measures analysis allowed each sub-
ject to serve as his or her own control so per-
sonal variables, except for age, were not
included in the models. Analyses were con-
ducted for the entire population of infants
(n = 691), and then repeated for the subset of
infants whose mothers had asthma (n = 61).
Results
As expected, approximately half the study
infants were boys, and > 40% were the only
child in the household (Table 1). Mothers of
the infants tended to be married (80%) and
white, non-Hispanic (75%). More than one-
third of the mothers had high school or less
education, while another 36% had college or
higher. There were no signiﬁcant differences
in distributions of these characteristics by
maternal asthma status, although there
appeared to be more pets in homes of asth-
matic mothers (51%) than nonasthmatic
mothers (42%).
Table 2 presents distributions of ambient
pollutants measured daily during the sum-
mers of 1995 and 1996. The mean (± SD)
24-hr average concentration of O3 across the
166 days of the study period was 35.2 ± 8.4
ppb. Mean concentration of both maximum
8-hr running average (54.5 ppb) and peak
1 hr (60.8 ppb) for this period were below the
U.S. EPA standards for these metrics of 80
ppb and 120 ppb, respectively (U.S. EPA
2006). The mean concentration of PM2.5
(23.2 µg/m3) was also well below the U.S.
EPA standard of 65 µg/m3 (U.S. EPA 2004).
The daily variability in the three different
metrics of O3 (24-hr average, maximum 8-hr
running average, and peak 1-hr average) are
shown for 1995 (Figure 1A) and 1996
(Figure 1B). Levels of O3 tended to be low
during the study period, with maximum 8-hr
running average exceeding the U.S. EPA stan-
dard of 80 ppb on only 2 days in 1995 and
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Table 1. Selected characteristics of the infant study population, southwestern Virginia, 1995–1996 [n (%)].
Mother does
Characteristic All infants not have asthma Mother has asthma
Infant sex 
Boy 361 (52.2) 324 (51.4) 37 (60.7)
Girl 330 (47.8) 306 (48.6) 24 (39.3)
No. of other children in household
0 298 (43.1) 274 (43.5) 24 (39.3)
1 250 (36.2) 230 (36.5) 20 (32.8)
≥ 2 143 (20.7) 126 (20.0) 17 (27.9)
Mother’s marital status
Married or cohabitating 550 (79.6) 499 (79.2) 51 (83.6)
Divorced 21 (3.0) 19 (3.0) 2 (3.3)
Separated 14 (2.0) 12 (1.9) 2 (3.3)
Never married 106 (15.3) 100 (15.9) 6 (9.8)
Mother’s race
White, non-Hispanic 519 (75.1) 471 (74.8) 48 (78.7)
African American 161 (23.3) 149 (23.6) 12 (19.7)
Hispanic 3 (0.4) 3 (0.5) 0 (0.0)
Asian 6 (0.9) 6 (1.0) 0 (0.0)
Other 2 (0.3) 1 (0.2) 1 (1.6)
Mother’s education
≤ High school 246 (35.6) 222 (35.2) 24 (39.4)
Some college 202 (29.2) 183 (29.0) 19 (31.2)
College 176 (25.5) 164 (26.0) 12 (19.7)
> College 67 (9.7) 61 (9.7) 6 (9.8)
Pets in home
No 393 (56.9) 363 (57.6) 30 (49.2)
Yes 298 (43.1) 267 (42.4) 31 (50.8)
Table 2. Distribution of pollutants over study period (n = 166 days), summers of 1995 and 1996.
25th–75th
Pollutant Mean ± SD Median Range percentile IQR
24-hr average O3 (ppb) 35.2 ± 8.4 35.7 13.5–56.6 28.8–40.6 11.8
8-hr maximum O3 (ppb) 54.5 ± 13.0 55.3 23.5–87.6 45.1–64.1 19.0
1-hr peak O3 (ppb) 60.8 ± 13.4 60.5 26.0–95.0 52.0–70.0 18.0
PM2.5 (µg/m3) 23.2 ± 10.3 22.3 3.5–59.6 15.7–29.4 13.7
Coarse (µg/m3) 6.2 ± 3.2 5.9 0.0–19.8 4.2–7.8 3.6no days in 1996. The 120-ppm 1-hr U.S.
EPA standard was not exceeded in either year.
Correlations between same-day and
previous-day concentrations of O3 were mod-
erate, r = 0.45–0.55 (data not shown), and
similar correlations were found between O3
and PM2.5. O3 measures were more highly
inversely correlated with humidity (r = –0.62
to –0.69) than positively correlated with tem-
perature (r = 0.26–0.55). Correlations between
the three O3 metrics ranged from 0.74 (24-hr
average with maximum 8-hr running average)
to 0.96 (maximum 8-hr running average with
peak 1 hr) (data not shown).
Lower respiratory symptoms (wheeze and
difﬁculty breathing) were infrequent in these
infants during the summer study period
(Table 3). For example only 8% of the 691
infants wheezed at least once during this
period, and of the 52,421 infant days of fol-
low-up contributed by the 691 infants, there
were 310 (0.6%) wheeze days. Infants whose
mothers had asthma were more likely to have
each of these symptoms than infants whose
mothers did not have asthma.
In the single-pollutant GEE models, none
of the O3 measures were associated with any
respiratory symptom among the total study
population of infants (Table 4, top). Among
the subset of infants whose mothers had
asthma (Table 4, bottom), same-day 24-hr
average O3 was more strongly and consistently
associated with lower respiratory symptoms
than either maximum running 8-hr average or
peak 1-hr O3. Same-day 24-hr average O3 was
statistically signiﬁcantly associated with wheeze
[odds ratio (OR) = 1.65; 95% confidence
interval (CI), 1.01–2.70 per IQR increase in
O3] and difﬁculty breathing (OR = 2.14; 95%
CI, 1.42–3.20). Previous-day 24-hr average O3
also approached statistical signiﬁcance with dif-
ficulty breathing (OR = 1.49; 95% CI,
0.96–2.32). Same-day maximum running 8-hr
average O3 (OR = 1.67; 95% CI, 1.02–2.73)
was significantly associated with difficulty
breathing but not wheeze, and peak 1-hr O3
was marginally associated with difficulty
breathing (OR = 1.64; 95% CI, 0.95–2.83).
None of the O3 measures were associated with
cough (data for cough not shown).
Three co-pollutant models were run for
each outcome and each O3 metric: model 1,
same-day pollutant measurements (O3, PM2.5,
and coarse particles); model 2, previous-day
pollutant measures; model 3, same-day and
previous-day pollutant measurements.
In co-pollutant models for all study infants
(Table 5, top), same-day 24-hr average O3 was
associated with wheeze in model 1 (OR = 1.41;
95% CI, 1.03–1.93) controlling for same-day
PM2.5, coarse particles, average temperature,
humidity, and infant age at the beginning of
follow-up, and in model 3 (OR = 1.37; 95%
CI, 1.02–1.84) controlling for same-day and
previous-day exposures. Same-day maximum
8-hr running average O3 was marginally associ-
ated with difﬁculty breathing in these models.
None of the O3 metrics were associated with
cough (data for cough not shown).
In co-pollutant models of the subset of
infants whose mothers had asthma, same-day
24-hr average O3 remained significantly
related to wheeze and difficulty breathing
(Table 5, bottom, models 1 and 3). In addi-
tion, previous-day 24-hr average O3 was asso-
ciated with difﬁculty breathing (models 2 and
3). Maximum 8-hr O3 and peak 1-hr O3 were
signiﬁcantly associated with difﬁculty breath-
ing, but not wheeze or cough. Effect estimates
for these two measures of O3 were generally
lower than those for 24-hr average O3. None
of the O3 measures were signiﬁcantly associ-
ated with cough, controlling for co-pollutants.
Discussion
In this study we examined the effects of rela-
tively low O3 levels on acute respiratory
symptoms in infants living in nonsmoking
households in southwestern Virginia. The
results of this study indicate that among the
subgroup of infants whose mothers had a his-
tory of physician-diagnosed asthma, exposure
to O3 at levels close to or below current U.S.
EPA guidelines increased the likelihood of
respiratory symptoms, controlling for PM2.5
and coarse particle exposure. The association
Ozone and infant respiratory symptoms
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Figure 1. Daily levels of ozone (24-hr average, peak 1-hr, maximum 8-hr average): (A) June 10–August 31, 1995; (B) June 10–August 31, 1996.
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Table 3. Frequency of respiratory symptoms and infant-days with symptoms in study infants, by maternal asthma status.
All infants Mother does not have asthma Mother has asthma
Percent of infants No. of infant-days Percent of infants No. of infant-days Percent of infants No. of infant-days
with symptoms with symptoms Symptom with symptoms with symptoms Symptom with symptoms with symptoms Symptom
Symptom (n = 691) (n = 52,421) ratea (n = 630) (n = 47,972) ratea (n = 61) (n = 4,449) ratea
Wheeze 8.2 310 0.6 7.5 275 0.6 16.4 35 0.8
Difﬁculty breathing 5.5 188 0.4 5.2 160 0.3 8.2 28 0.6
Wheeze and/or 10.9 428 0.8 10.2 384 0.8 18.0 44 1.0
difﬁculty breathing
Cough 35.9 1,899 3.6 34.4 1,700 3.5 50.8 199 4.5
aDays of symptoms per 100 infant-days of follow-up.between same-day 24-hr average O3 and
wheeze, controlling for particle exposure, was
weaker but signiﬁcant for the overall group of
infants in the study.
Earlier U.S. EPA standards were based on
peak 1-hr O3 exposures (120 ppb), but the
standards were revised in 1997 after the 1-hr
standard was determined to be inadequate for
protecting human health (U.S. EPA 2006).
The new standard, based on maximum run-
ning 8-hr average, is 80 ppb. In our study,
there were no days on which the earlier peak
1-hr standard was exceeded in either 1995 or
1996, and only 2 days on which revised maxi-
mum 8-hr average O3 standard was exceeded
(both in 1995). Although associations were
found between each of these metrics and res-
piratory symptoms in the subgroup of infants
whose mothers had asthma, our ﬁndings sug-
gest that 24-hr average O3 was more consis-
tently and strongly associated with acute
respiratory symptoms than the standard
metrics (peak 1-hr O3 and maximum 8-hr
average) in these infants.
Several strengths of this study are worth
noting. First, this was one of the ﬁrst studies
examining effects of O3 exposure on infants
of mothers with asthma, a potentially vulnera-
ble subpopulation. Although asthma is not
typically diagnosed in the first year of life,
wheezing is fairly common in all infants, most
likely a consequence of the small size of infant
airways and incomplete stage of lung develop-
ment at birth (Finkelstein and Johnston
2004; Mathieu-Nolf 2002). Thus, all infants
may be vulnerable to the effects of air pollu-
tants. The ﬁndings of this study suggest that
we may be able to identify at birth children
who are at particular risk of O3-related respi-
ratory effects, namely, those born to mothers
who have asthma.
Second, our analytical approach using
GEE exploited the repeated nature of the
exposure assessment. The approach allows for
greater statistical power with a smaller num-
ber of subjects while accounting for autocor-
relation between repeated observations. We
also considered both single-pollutant and co-
pollutant (PM2.5 and coarse particles) models
and controlled for temperature and humidity
in all models. Although we presented only the
ﬁndings for same-day and previous-day expo-
sures, we also examined 3-day and 5-day aver-
age O3 exposures with similar results: 24-hr
average O3 was more strongly associated with
respiratory symptoms than peak 1-hr O3 or
maximum 8-hr running average O3 measures.
Third, we considered various metrics of
O3 exposure, including 24-hr average, peak
1-hr O3, and maximum 8-hr running average.
Different studies have used different metrics
Triche et al.
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Table 4. Single-pollutant modelsa of associations between O3 measures and respiratory symptoms among
all infants and among infants whose mothers had asthma [OR (95% CI)].b
O3 exposure Wheeze Difﬁculty breathing
All infants
24-hr average
Same day 1.32 (0.91–1.92) 1.10 (0.69–1.75)
Previous day 1.18 (0.93–1.50) 1.07 (0.75–1.54)
Maximum 8-hr running average
Same day 1.04 (0.76–1.43) 1.17 (0.77–1.77)
Previous day 1.11 (0.89–1.38) 1.10 (0.79–1.53)
Peak 1-hr
Same day 1.00 (0.77–1.31) 1.09 (0.78–1.52)
Previous day 1.12 (0.92–1.36) 1.04 (0.77–1.41)
Infants with mothers who have asthma
24-hr average
Same day 1.65* (1.01–2.70) 2.14* (1.42–3.20)
Previous day 1.47 (0.78–2.77) 1.49 (0.96–2.32)
Maximum 8-hr running average
Same day 1.28 (0.64–2.54) 1.67* (1.02–2.73)
Previous day 1.29 (0.70–2.37) 1.49 (0.73–3.06)
Peak 1-hr
Same day 1.28 (0.72–2.30) 1.64 (0.95–2.83)
Previous day 1.19 (0.67–2.11) 1.39 (0.76–2.56)
aAll single-pollutant models control for 24-hr average temperature, humidity, and infant’s age at beginning of summer
study period; lag 1 = previous day. bOR per IQR increase in O3: 24-hr average O3 = 11.8 ppb; 8-hr maximum O3 = 19.0 ppb;
1-hr peak O3 = 18.0 ppb. *p < 0.05.
Table 5. Co-pollutant modelsa of associations between O3 measures and respiratory symptoms among all infants and among infants whose mothers had asthma,
southwestern Virginia, 1995–1996 [OR (95% CI)].b
Wheeze Difﬁculty breathing
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
O3 exposurec (same day) (previous day) (same and previous day) (same day) (previous day) (same and previous day)
All infants
24-hr average
Same day 1.41* (1.03–1.93) 1.37* (1.02–1.84) 1.28 (0.84–1.93) 1.19 (0.88–1.62)
Previous day 1.24 (0.96–1.59) 1.13 (0.90–1.44) 1.18 (0.83–1.68) 1.12 (0.82–1.52)
Maximum 8-hr running average
Same day 1.08 (0.81–1.44) 1.03 (0.79–1.34) 1.37 (0.99–1.89) 1.28 (0.96–1.71)
Previous day 1.15 (0.90–1.47) 1.15 (0.94–1.42) 1.23 (0.90–1.68) 1.19 (0.88–1.61)
Peak 1-hr
Same day 1.03 (0.81–1.32) 0.98 (0.77–1.24) 1.23 (0.95–1.59) 1.18 (0.94–1.49)
Previous day 1.14 (0.92–1.42) 1.15 (0.95–1.40) 1.13 (0.85–1.51) 1.11 (0.43–1.46)
Infants with mothers who have asthma
24-hr average
Same day 1.91* (1.24–2.94) 1.59* (1.00–2.54) 2.31* (1.26–3.69) 1.83* (1.42–2.36)
Previous day 1.53 (0.94–2.49) 1.45 (0.83–2.76) 1.66* (1.11–2.47) 1.53* (1.02–2.28)
Maximum 8-hr running average
Same day 1.62 (0.75–3.49) 1.36 (0.54–3.43) 1.99* (1.33–2.96) 1.55* (1.02–2.35)
Previous day 1.39 (0.84–2.32) 1.51 (0.96–2.36) 1.57* (1.09–2.26) 1.92* (1.24–2.95)
Peak 1-hr
Same day 1.57 (0.86–2.86) 1.39 (0.71–2.71) 1.96* (1.28–2.99) 1.73* (1.12–2.66)
Previous day 1.25 (0.74–2.13) 1.30 (0.76–2.22) 1.50* (1.19–2.44) 1.70* (1.19–2.43)
aAll co-pollutant models control for PM2.5, coarse particles, 24-hr average temperature, humidity and infant’s age at beginning of summer study period; lag 1 = previous day. bOR per IQR
increase in O3: 24-hr average O3 = 11.8 ppb; 8-hr maximum O3 = 19.0 ppb; 1-hr peak O3 = 18.0 ppb. cSeparate models were run for each O3 exposure metric (24-hr average, maximum 8-hr
running average, and peak 1-hr O3). *p < 0.05.of O3 exposure, perhaps accounting for some
of the inconsistency in ﬁndings. By systemati-
cally examining all three metrics, despite the
fact that they were strongly correlated, our
findings indicate that 24-hr average may be
more relevant to respiratory symptoms than
either of the two metrics on which U.S. EPA
standards are based.
Finally, another important strength of the
study was the exclusion of any infants with
smoking in their household. Considerable
evidence suggests that environmental tobacco
smoke (ETS) is associated with respiratory
symptoms in children (Harlap and Davies
1974; Rantakallio 1978). By including only
nonsmoking households, we avoided residual
confounding by ETS exposure.
There were some study limitations. Only
a small number of infants had asthmatic
mothers (n = 61), limiting the power of the
study to detect small but important effects.
However, infants were followed for up to
83 days each, and the analysis allowed them
to serve as their own controls. Furthermore,
we were able to detect signiﬁcant associations
in this subgroup, indicating that power was
not an issue for many associations of interest.
In addition, although we controlled for
particle exposure, there may be additional
confounders or co-pollutants that were not
accounted for in this analysis (e.g., sulfur diox-
ide and nitrogen dioxide). Although these
concentrations were available from central
sites, we did not include them in our final
models, because they tend to be local rather
than regional pollutants. However, we found
no differences in our O3 ﬁndings when central
site SO2 and NO2 concentrations were
included (data not shown). Nonetheless, it is
possible that other co-pollutants or combina-
tions of pollutants not accounted for in these
analyses may partially explain our O3 ﬁndings.
The analysis was limited to infants from
Virginia, and the results may not be generaliz-
able to other areas in which the mix or sources
of ambient pollutants differ. Importantly, our
ﬁndings replicate those for our older asthmatic
cohort in Connecticut (Gent et al. 2003), an
area where comparable O3 concentrations were
recorded (1-hr and 8-hr averages were 58.6 ppb
and 55.5 ppb for 1-hr levels and 51.3 ppb and
50.0 ppb for 8-hr levels). PM2.5 levels in the
Connecticut study (mean = 13.1 µg/m3;
median = 10.3 µg/m3), however, were approxi-
mately half those measured in this study.
Another potential study limitation was
that measures of exposure were based on
central site rather than personal exposure
measurements. However, in a prior study
(Gent et al. 2003), we found that levels of
ambient PM2.5 and O3 tended to be regional,
with median correlations between sites
located throughout Connecticut of 0.91 for
particles and 0.81 for O3.
Symptoms were reported by mothers of
study infants; we did not receive physician
confirmation of wheeze or difficulty breath-
ing. It is possible that asthmatic mothers were
more likely to recognize symptoms in their
infants because of their own personal experi-
ence and thus might be more likely to report
asthma symptoms in their infants than would
nonasthmatic mothers. However, the overall
correlation between mother’s and infant’s
symptom-days was only 0.05, indicating that
mother’s wheeze experiences during the study
were unrelated to reporting of wheeze in her
infant. In addition, physician confirmation
depends mainly on the mother bringing the
child in for a visit, which would also be based
on the mother’s assumptions about whether
her child was wheezing, as well as access to
medical care. Thus, using medical chart
review for confirmation of symptoms does
not necessarily remove bias.
Our ﬁnding that O3 exposure at these lev-
els was inconsistently related to acute respira-
tory symptoms in the general cohort of infants
is in agreement with several studies failing to
ﬁnd an association between O3 and symptoms
in healthy, primarily school-age children
(Cuijpers et al. 1994, 1995; Linn et al. 1996;
Steerenberg et al. 2003). However, four studies
did find significant associations between O3
and respiratory symptoms (Berry et al. 1991;
Castillejos et al. 1992; Schlink et al. 2002;
Schwartz et al. 1994). Two of these studies
found effects of O3 only above deﬁned thresh-
old levels: 30 ppb (Schlink et al. 2002) and
120 ppb (Berry et al. 1991). Another of the
studies was in Mexico City (Castillejos et al.
1992), where O3 concentrations regularly
exceed U.S. EPA standards (U.S. EPA 2006).
The fourth study (Schwartz et al. 1994) of 300
schoolchildren from six cities found O3 related
to cough, but only single-pollutant models
were analyzed. An additional study (Ward
et al. 2002) found inconsistent associations
between 24-hr average O3 and symptoms
among 162 inner-city children 9 years of age.
In contrast, we found that infants whose
mothers had asthma were at consistently
increased risk of respiratory symptoms with
increasing O3 exposure. It appears that this
subgroup is particularly susceptible to the
effects of O3. According to the U.S. Clean Air
Act (1990), air quality standards must be set
low enough to protect susceptible subgroups
of the population. Our ﬁnding extends those
of several studies (Moss et al. 2001; Thurston
et al. 1997), including our own (Gent et al.
2003), that identify vulnerable subgroups that
may not be protected by current standards.
Many (Buchdahl et al. 2000; Delﬁno et al.
1998; Gent et al. 2003; Gielen et al. 1997; Just
et al. 2002; Mortimer et al. 2000; Romieu et al.
1996, 1997; Schlink et al. 2002; Thurston et al.
1997) but not all (Jalaludin et al. 2004;
McConnell et al. 1999; Ostro et al. 2001;
Ward et al. 2002) studies in children with
asthma or allergies have found that O3 exposure
is signiﬁcantly associated with respiratory symp-
toms or medication use in this high-risk group.
Differences in these ﬁndings may be due to dif-
ferent O3 metrics, co-pollutant versus single-
pollutant models, different levels of ambient
O3, or different time periods or seasons.
Jalaludin et al. (2004) concluded that O3 was
not related to respiratory symptoms or medica-
tion use in Australian schoolchildren. However,
the study covered an 11-month period includ-
ing the winter, when symptoms tend to be
more frequent and O3 is at its lowest.
Conclusion
Our data provided a unique opportunity to
examine the influence of O3 and particle
exposures on respiratory symptoms in infants
living in nonsmoking households. This
cohort was followed for a long time, with
regular (approximately biweekly) reporting of
daily symptoms, and ambient co-pollutants
were measured and accounted for in analyses.
Even at low levels of O3 exposure, infants are
at significantly increased risk of respiratory
symptoms, particularly if their mothers have a
history of physician-diagnosed asthma. This
may be linked to a genetic predisposition for
asthma, but this susceptibility to the effects of
air pollution appears to be identiﬁable as early
as the ﬁrst year of life, long before a diagnosis
of asthma can be made in these infants.
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